UK MHRA okays Marksans Pharma anti-diarrhoea drug Loperamide
New Delhi: Marksans Pharma Limited has announced that UK MHRA has granted Market Authorisation to the Company's wholly owned subsidiary Relonchem Limited for Loperamide 2mg Hard Capsules.
Loperamide Capsules is an anti-diarrhoea medication.
Marksans will manufacture the products at its UK MHRA approved state-of-the-art oral dosage facility located at Goa, India.
Read also: Marksans Pharma gets USFDA nod for Acetaminophen ER Tablets
Marksans Pharma, headquartered at Mumbai (India) is a global pharmaceutical company.
The company's key focus areas lie in the OTC & prescription drugs that have wide-ranging applications across fields like Oncology, Gastroenterology, Antidiabetic, Antibiotics, Cardiovascular, Pain Management, Gynaecology, among others.
Read also: Marksans Pharma appoints Dr Meena Rani Surana as Independent Woman Directo
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.